Rasagiline - A novel MAO B inhibitor in Parkinson's disease therapy

Shimon Lecht, Simon Haroutiunian, Amnon Hoffman, Philip Lazarovici*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

56 Scopus citations

Fingerprint

Dive into the research topics of 'Rasagiline - A novel MAO B inhibitor in Parkinson's disease therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds

Engineering & Materials Science

Social Sciences